Portrait of Kean, Thomas H.

Kean, Thomas H.

U.S. Representative NJ-7 Republican Party

Congressional stock trade history disclosed under the STOCK Act, as filed.

Disclosed trades
194
Buys / sells
43% / 44%
Last trade
Oct 27, 2026
Last filing
Nov 19, 2026

Latest disclosed trades

Latest 10 of 194
Ticker Type Traded
JNJ Sell Oct 27, 2026
SYK Sell Oct 27, 2026
MSFT Sell Oct 27, 2026
— U.S. Treasury Note [GS] F S: New Buy Oct 20, 2026
WBD Sell Oct 7, 2026
WBD Sell Oct 7, 2026
JNJ Sell Sep 30, 2026
SYK Sell Sep 30, 2026
ESAB Buy Sep 29, 2026
MDLZ Sell Sep 23, 2026

Amounts are reported as STOCK Act range buckets, not exact dollar values. Trade dates are the date the politician executed the trade; filing dates are when the disclosure was filed. Sign up to filter by ticker, amount range, or filing window.

Kean, Thomas H. stock trade activity

FilingIQ has indexed 194 congressional stock trade disclosures for Kean, Thomas H.. The most recent disclosed transaction is dated Oct 27, 2026.

Across the full history, 83 purchases and 86 sales have been disclosed under the STOCK Act.

Top tickers traded by Kean, Thomas H.

Frequently asked

How many stock trades has Kean, Thomas H. disclosed?
FilingIQ tracks 194 Periodic Transaction Report disclosures for Kean, Thomas H., with the most recent dated Oct 27, 2026. Every entry sources back to the official House Office of the Clerk or Senate Office of Public Records.
Is Kean, Thomas H. a net buyer or net seller?
Across the disclosed trade history, 83 (43%) were purchases and 86 (44%) were sales. Compensation and exchanges are filtered out of these counts.
Where does FilingIQ's data on Kean, Thomas H. come from?
Every trade shown on this page is sourced from the STOCK Act disclosures filed with the House or Senate. FilingIQ normalizes ticker resolution, dates, and amount brackets across both chambers.

Methodology & sources

Disclosures parsed from official House Office of the Clerk and Senate Office of Public Records filings. Methodology documented on methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.